Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRC-003 in Refractory Post-Traumatic Epilepsy
NCT06523725Phase 2Withdrawn
- Start
- Nov 2024
- Primary completion
- Apr 2025
- Countries
- 1
01
Overview
A Phase 2 trial of BRC-003 in post-traumatic epilepsy (PTE). Planned start Nov 2024; status: withdrawn.
02
Drugs
BRC-003
03
Conditions
post-traumatic epilepsy (PTE)
Beyond the preview
Go deeper on NCT06523725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06523725.